Royalty Pharma Dividend

What is Royalty Pharma current dividend yield, its reliability and sustainability?

[object Object] Score

2/6

Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


1.77%

Current Dividend Yield

Dividend Yield vs Market

Royalty Pharma Dividend Yield vs Market
How does RPRX dividend yield compare to the market?
SegmentDividend Yield
Company (RPRX)1.8%
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast in 3 Years (RPRX)2.0%

Notable Dividend: RPRX's dividend (1.77%) is higher than the bottom 25% of dividend payers in the US market (1.5%).

High Dividend: RPRX's dividend (1.77%) is low compared to the top 25% of dividend payers in the US market (4.22%).


Stability and Growth of Payments

How stable has Royalty Pharma's dividend per share been in the past?
MonthDividend Per Share (annual)Avg. Yield (%)
12/31/20240.954
12/31/20230.845
12/31/20220.785
12/5/20220.761.77
10/18/20220.761.79
7/18/20220.761.79
4/19/20220.761.85
1/6/20220.761.92
10/15/20210.681.73
7/16/20210.681.79
4/15/20210.681.61
1/8/20210.681.47
10/15/20200.61.41
9/2/20200.61.44

Stable Dividend: Whilst dividend payments have been stable, RPRX has been paying a dividend for less than 10 years.

Growing Dividend: RPRX's dividend payments have increased, but the company has only paid a dividend for 2 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (63.6%), RPRX's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (115.1%), RPRX's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies